Paul Mussenden

Paul Mussenden is a seasoned life science and health-tech executive with extensive experience in building businesses and leading organizational growth.

Currently, he serves as the CEO of Cydar Ltd, where he oversees corporate strategy, regulatory and IP strategy, business development, M&A, fundraising, commercial development, corporate governance, risk management, and team leadership.

In addition to his role at Cydar Ltd, Paul Mussenden is a non-executive director at DRI Healthcare Trust and LifeArc, demonstrating his commitment to contributing to the healthcare and life science sectors through strategic advisory roles.

Paul's diverse professional background includes positions such as General Counsel, Company Secretary & Head of Strategic Affairs at BTG plc, Equity Markets Advisor at London Stock Exchange, and Associate at Norton Rose Group, highlighting his broad expertise in legal affairs and financial markets.

His leadership experience includes serving as a Non-executive Deputy Chairman, Chair of Audit & Risk Management Committee at LifeArc Limited, emphasizing his proficiency in governance and risk management.

Paul Mussenden's educational background includes studies in an undisclosed field that have equipped him with the knowledge and skills necessary for his successful career in the life science and health-tech industries.